France· FR:65820786
MAVENCLAD 10 mg, comprimé
A medicinal product containing cladribine, registered in France by MERCK SERONO EUROPE (ROYAUME-UNI), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CLADRIBINE
- Manufacturer
- MERCK SERONO EUROPE (ROYAUME-UNI)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 3
3 priced- cip133400930111796plaquette(s) aluminium de 1 comprimé(s)EUR 1.23
- cip133400930111819plaquette(s) aluminium de 4 comprimé(s)EUR 4.69
- cip133400930111833plaquette(s) aluminium de 6 comprimé(s)EUR 6.96
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cladribine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMAVENCLADMerck Europe B.V., Amsterdam
- United StatesCladribineApotex Corp.
- FinlandMAVENCLADMerck Europe B.V.
- SwitzerlandMavenclad 10 mg, TablettenMerck (Schweiz) AG
- NorwayMavencladMerck Europe B.V.
- NetherlandsMavenclad 10 mg tablettenMerck Europe B.V.
- PolandMavencladMerck Europe B.V.
- SwedenMAVENCLAD 10 mg TablettMerck Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Leuject
- Belgium · Leustatin
- Bulgaria · Леуджект
- Czechia · Leuject
- Germany · Leustatin
- Spain · Leustatin
- Finland · Leuject
- United Kingdom (Northern Ireland) · Cladribine Zentiva, Leustat
- Greece · Leustatin
- Croatia · Leuject
- Hungary · Leuject
- Iceland · Mavenclad
- Italy · Leustatin
- Liechtenstein · Mavenclad
- Luxembourg · Leustatin
- Netherlands · Leustatin
- Norway · Leuject, Mavenclad
- Poland · Biodribin, Leuject
- Portugal · Cladribina Generis, Leustatin
- Romania · Leuject
- Sweden · Leuject
- Slovenia · Leuject
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d4b74911-15c3-4d2b-9d94-52b97e580ae0 GET /v1/drugs/d4b74911-15c3-4d2b-9d94-52b97e580ae0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65820786",
"date_amm": "2017-08-22",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/17/1212",
"substance": "CLADRIBINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about cladribine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.